Table 1 Administrative information showing key SPIRIT checklist items

Title {1}

Pneumococcal conjugate vaccination schedules in infants - acquisition, immunogenicity and pneumococcal conjugate and yellow fever vaccine co-administration study

Trial registration

{2a} and {2b}

International Standard Randomised Controlled Trials Number – 72821613, https://doi.org/10.1186/ISRCTN72821613. Registered on 28 November 2019.

Protocol version {3}

Protocol version 5.0, 24 May 2021

Funding {4}

Bill & Melinda Gates Foundation (INV006724); Mucosal Pathogens Research Unit, University College London (Ref 5356358), National Institute of Health Research (UK); Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine.

Author details {5a}

Grant A Mackenzie^1,2,3,4, Isaac Osei^1,2, Rasheed Salaudeen¹, Ousman Secka¹, Umberto D’Alessandro¹, Ed Clarke¹, Jonas Schmidt-Chanasit⁵, Paul V Licciardi³, Cattram Nguyen³, Brian Greenwood², Kim Mulholland^3,4,6

1 Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Fajara, The Gambia.

2 Faculty of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.

3 Murdoch Children’s Research Institute, Melbourne, Australia.

4 Department of Paediatrics, University of Melbourne, Australia.

5 Bernard Nocht Institute for Tropical Medicine, Hamburg, Germany

6 Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, UK.

Contact information for trial sponsor {5b}

London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. Contact name: Head of Research Governance and Integrity, RGIO@lshtm.ac.uk.

Role of sponsor and funder {5c}

The trial sponsor and funders are not involved in the study design; collection, management, analysis and interpretation of data; writing of the report; the decision to submit the report for publication, and will not have authority over any of these activities.